GeneLink, Inc. GNLK Company Overview  Stock Message Board

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
GeneLink, Inc. GNLK Company Overview 

Stock Message Board http://investorshangout.com/search?q=GNLK&...mp;yt1=Go!

GeneLink, Inc. GNLK Current Price and Quotes
0.0062
Previous Close
0.008
Open
0.0062

Daily Range
0.0062 - 0.0062
52wk Range
0.1915 - 0.0025

Volume
9,000
Dividend
N/A

Average Vol (3m)
127,195
Yield
N/A

GeneLink, Inc. GNLK
Company Information
8250 Exchange Drive
Suite 120
Orlando, FL 32835

Website: http://www.genelinkbio.com
Phone: 800-558-4363
Email: IR@genelinkbio.com

GeneLink, Inc. GNLK
Genetically customized health and wellness solutions

GeneLink, Inc. GNLK
Financial Reportings and Disclosures
Reporting Status U.S. Reporting: SEC Filer
Audited Financials Audited
Latest Report Jun 30, 2013 10-Q
CIK 0000941020
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8071 - Medical laboratories
Incorporated In: PA, USA
Year of Inc. 1994
Employees Not Available
Company Officers/Contacts
Bernard L. Kasten, Jr. MD President, CEO
Company Directors
Bernard L. Kasten, Jr. MD Chairman
Douglas Boyle
Richard Ricciardi
Company Notes
Note=12-98 company is in the development stage
Service Providers
Auditor/Accountant
Not Available
Legal Counsel
Not Available
Investor Relations Firm
Not Available

GeneLink, Inc. GNLK
GNLK Security Details
Share Structure
Market Value1 $1,627,616 a/o Aug 30, 2013
Shares Outstanding 262,518,689 a/o Aug 14, 2013
Float Not Available
Authorized Shares 350,000,000 a/o May 27, 2011
Par Value  0.01
Shareholders
Shareholders of Record 218 a/o Apr 01, 2013
Short Selling Data
Short Interest 0 (-100%)
Jul 15, 2013
Significant Failures to Deliver  No
Transfer Agent(s)
Broadridge Financial Solutions, Inc.

GeneLink, Inc. GNLK Recent News

GeneLink, Inc. GNLK Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010 Dec 31, 2009
Total Revenue 2,136 4,685 7,840 8,561
Cost of Revenue 1,671 1,735 2,861 3,655
Gross Profit 465 2,950 4,979 4,907
Operating Expenses
Research and Development 251 135 51 45
Sales, General and Admin. 3,508 6,247 7,171 7,324
Non-Recurring Items - - - -
Other 175 135 160 -
Operating Income (3,469) (3,567) (2,403) (2,462)
Income From Continuing Operations
Add'l Income/Expense Items 748 2 2 (126)
Earnings Before Interest and Tax (2,721) (3,564) (2,401) (2,588)
Interest Expense 331 266 234 129
Earnings Before Tax (3,052) (3,830) (2,635) (2,717)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,052) (3,830) (2,635) (2,717)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,052) (3,830) (2,635) (2,717)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (3,052) (3,830) (2,635) (2,717)

GNLK GeneLink, Inc. Research DD Guide

GNLK GeneLink, Inc. Stock Message Board http://investorshangout.com/search?q=GNLK&...mp;yt0=Go!
GNLK GeneLink, Inc. Stock Quote http://www.otcmarkets.com/stock/GNLK/quote
GNLK GeneLink, Inc. Stock Chart http://www.otcmarkets.com/stock/GNLK/chart
GNLK GeneLink, Inc. Company Info http://www.otcmarkets.com/stock/GNLK/company-info
GNLK GeneLink, Inc. Recent News http://www.otcmarkets.com/stock/GNLK/news
GNLK GeneLink, Inc. Financials http://www.otcmarkets.com/stock/GNLK/financials
GNLK GeneLink, Inc. Filings and Disclosure http://www.otcmarkets.com/stock/GNLK/filings
GNLK GeneLink, Inc. Short Sales http://www.otcmarkets.com/stock/GNLK/short-sales
GNLK GeneLink, Inc. Insider Disclosure http://www.otcmarkets.com/stock/GNLK/insider-transactions
GNLK GeneLink, Inc. Research Reports http://www.otcmarkets.com/stock/GNLK/research
GNLK GeneLink, Inc. Summary http://finance.yahoo.com/q?s=GNLK
GNLK GeneLink, Inc. Historical Prices http://finance.yahoo.com/q/hp?s=GNLK+Historical+Prices
GNLK GeneLink, Inc. Interactive Chart http://finance.yahoo.com/echarts?s=GNLK
GNLK GeneLink, Inc. Basic Chart http://finance.yahoo.com/q/bc?s=GNLK+Basic+Chart
GNLK GeneLink, Inc. Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=GNLK+Basic+Tech.+Analysis
GNLK GeneLink, Inc. Headlines http://finance.yahoo.com/q/h?s=GNLK+Headlines
GNLK GeneLink, Inc. Press Releases http://finance.yahoo.com/q/p?s=GNLK+Press+Releases
GNLK GeneLink, Inc. Company Profile http://finance.yahoo.com/q/pr?s=GNLK+Profile
GNLK GeneLink, Inc. Key Statistics http://finance.yahoo.com/q/ks?s=GNLK+Key+Statistics
GNLK GeneLink, Inc. Industry http://finance.yahoo.com/q/in?s=GNLK+Industry
GNLK GeneLink, Inc. Major Holders http://finance.yahoo.com/q/mh?s=GNLK+Major+Holders
GNLK GeneLink, Inc. Insider Transactions http://finance.yahoo.com/q/it?s=GNLK+Insider+Transactions
GNLK GeneLink, Inc. Insider Roster http://finance.yahoo.com/q/ir?s=GNLK+Insider+Roster
GNLK GeneLink, Inc. Income Statement http://finance.yahoo.com/q/is?s=GNLK
GNLK GeneLink, Inc. Balance Sheet http://finance.yahoo.com/q/bs?s=GNLK
GNLK GeneLink, Inc. Cash Flow http://finance.yahoo.com/q/cf?s=GNLK+Cash+Flow&annual
GNLK GeneLink, Inc. Nasdaq http://www.nasdaq.com/symbol/GNLK
GNLK GeneLink, Inc. Market Watch http://www.marketwatch.com/investing/stock/GNLK
GNLK GeneLink, Inc. Bloomberg http://www.bloomberg.com/quote/GNLK:US
GNLK GeneLink, Inc. Morningstar http://quotes.morningstar.com/stock/s?t=GNLK
GNLK GeneLink, Inc. Bussinessweek http://investing.businessweek.com/research/st...icker=GNLK
GNLK GeneLink, Inc. Barchart http://www.barchart.com/quotes/stocks/GNLK
GNLK GeneLink, Inc. OTC Short Report http://otcshortreport.com/index.php?index=GNLK
GNLK GeneLink, Inc. Investopedia http://www.investopedia.com/markets/stocks/GNLK/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Kohl's Earnings Expectations: What Investors Need to Know

Updated Category News Views 89

Kohl's Earnings Preview: Investor Insights Kohl's (NYSE: KSS) is set to reveal its quarterly earnings report soon. Anticipations among investors are high as they await crucial details that might affect stock movements. Analysts are projecting an earnings per share (EPS) of $0.31, which could indicate trends worth examining for future investment strategies. Importance of...

Continue Reading
Challenges Facing US Crypto Reserve Expansion Beyond Bitcoin

Updated Category News Views 121

Concerns Over U.S. Crypto Reserve Expansion Analysts have raised significant concerns regarding the proposed U.S. Crypto Strategic Reserve and its expansion beyond Bitcoin. With financial backing potentially coming from Federal Reserve or Treasury funds, experts argue that significant hurdles remain. Market Response to Presidential Announcement The announcement of the...

Continue Reading
Financial Instability: A Key Barrier to America’s Health

Updated Category News Views 202

Understanding Financial Instability's Impact on Health The National Financial Educators Council (NFEC) recently raised an alarm regarding the Make America Healthy Again (MAHA) movement, emphasizing that without addressing financial instability, this initiative may fall short of its goals. The NFEC is advocating for a nationwide acknowledgment of financial instability as a...

Continue Reading
U.S. Labor Market Strong Despite Economic Challenges Ahead

Updated Category News Views 178

U.S. Labor Market Shows Resilience Amid Economic Changes Recently released job figures have painted a picture of a robust U.S. labor market. Despite some signs of slowing down, the overall state remains encouraging, with unemployment stabilizing around 4.1%. This is consistent with what is generally perceived as full employment levels. Raphael Bostic, the President of the...

Continue Reading
Intelligent Bio Solutions Set for Key Conference Participation

Updated Category News Views 106

Intelligent Bio Solutions Inc. at the Upcoming Micro-Cap Conference Intelligent Bio Solutions Inc. (NASDAQ: INBS) is excited to announce its participation in an important micro-cap virtual conference. This event provides a significant platform for the company's management team to engage with investors and showcase their cutting-edge technologies. Put aside any...

Continue Reading